C07K 14/00
Peptides having more than 20 amino acids
Official title: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/00 (Peptides having more than 20 amino acids) appears on 81,438 US grants and 108,770 published applications in this corpus.
Search patents in C07K- Granted patents
- 81,438
- Published applications
- 108,770
- Assignees
- 21,429
- Inventors
- 149,280
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 64 | 0 |
| 1977 | 77 | 0 |
| 1978 | 126 | 0 |
| 1979 | 71 | 0 |
| 1980 | 117 | 0 |
| 1981 | 110 | 0 |
| 1982 | 104 | 0 |
| 1983 | 120 | 0 |
| 1984 | 171 | 0 |
| 1985 | 143 | 0 |
| 1986 | 171 | 0 |
| 1987 | 276 | 0 |
| 1988 | 285 | 0 |
| 1989 | 373 | 0 |
| 1990 | 323 | 0 |
| 1991 | 473 | 0 |
| 1992 | 674 | 0 |
| 1993 | 836 | 0 |
| 1994 | 816 | 0 |
| 1995 | 925 | 0 |
| 1996 | 1295 | 0 |
| 1997 | 2110 | 0 |
| 1998 | 3168 | 0 |
| 1999 | 3081 | 0 |
| 2000 | 2599 | 0 |
| 2001 | 2756 | 488 |
| 2002 | 2398 | 4220 |
| 2003 | 2248 | 7579 |
| 2004 | 2002 | 4840 |
| 2005 | 1703 | 4588 |
| 2006 | 2484 | 4080 |
| 2007 | 2519 | 3553 |
| 2008 | 2249 | 3432 |
| 2009 | 2246 | 4075 |
| 2010 | 2502 | 3964 |
| 2011 | 2353 | 3712 |
| 2012 | 2166 | 3206 |
| 2013 | 2208 | 3319 |
| 2014 | 2369 | 3542 |
| 2015 | 2344 | 3526 |
| 2016 | 2418 | 3760 |
| 2017 | 2473 | 3604 |
| 2018 | 2496 | 3979 |
| 2019 | 2777 | 4522 |
| 2020 | 2936 | 4750 |
| 2021 | 2883 | 5115 |
| 2022 | 2726 | 5310 |
| 2023 | 2452 | 5233 |
| 2024 | 2672 | 5713 |
| 2025 | 2733 | 4959 |
| 2026 | 1817 | 3701 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07K 14/435From animals53,938
- C07K 14/005From viruses10,803
- C07K 14/195From bacteria10,579
- C07K 14/415From plants4,957
- C07K 14/001Peptides having more than 20 amino acids: by chemical synthesis1,819
- C07K 14/81Protease inhibitors1,754
- C07K 14/82Translation products from oncogenes1,457
- C07K 14/37From fungi1,456
Recent patents
- Methods of preparation of pan TLR antagonistic liposomal-LNP formulations and uses thereof6 Oct 2026US 12,751,920 B2Celestial Therapeutics, Inc.
- Methods and compositions for treating cardiovascular diseases using fat specific protein 27 (FSP27) compositions6 Oct 2026US 12,751,992 B2Ohio University
- Compositions, methods and kits for treating complement related disorders6 Oct 2026US 12,751,993 B2Trustees of Tufts College
- Mutant influenza B/Victoria lineage virus hemagglutinin proteins6 Oct 2026US 12,752,001 B2ModernaTX, Inc.
- Polypeptides, compositions, and their use to treat or limit development of an infection6 Oct 2026US 12,752,002 B2University of Washington
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- System, method, and apparatus for bioinspired strategies for efficient light harvesting and optical processing8 Oct 2026US 2026/0305745 A1Trustees of Tufts College
- Active loading of biomolecular cargo into engineered vesicles8 Oct 2026US 2026/0306415 A1Northwestern University
- Extracellular vesicles for the delivery of payloads to eukaryotic cells8 Oct 2026US 2026/0306416 A1Alaya.bio Inc.
- Application of CCR5hi Innate Immune Memory Cells in Preparation of Immunotherapeutic Drug for Treating Sepsis8 Oct 2026US 2026/0306538 A1Children's Hospital of Soochow University
Most cited
By later US patents
- Process for amplifying nucleic acid sequences5,960US 4,683,202 ACetus Corporation · 1987
- Directed evolution of novel binding proteins2,450US 5,223,409 AProtein Engineering Corporation · 1993
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996